Drug Shortage Report for MIDAZOLAM INJECTION

Last updated on 2019-07-26 History
Report ID 73217
Drug Identification Number 02242905
Brand name MIDAZOLAM INJECTION
Common or Proper name Midazolam Injection
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) MIDAZOLAM
Strength(s) 5MG
Dosage form(s) LIQUID
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 1mL
ATC code N05CD
ATC description HYPNOTICS AND SEDATIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2019-02-15
Actual start date
Estimated end date 2019-07-31
Actual end date 2019-07-24
Shortage status Resolved
Updated date 2019-07-26
Company comments Sandoz is an alternate supplier of Midazolam Injection, and have been informed of our impending supply interruptions.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2019-07-26 French Compare
v10 2019-07-26 English Compare
v9 2019-07-05 French Compare
v8 2019-07-05 English Compare
v7 2019-05-24 French Compare
v6 2019-05-24 English Compare
v5 2019-04-09 French Compare
v4 2019-04-09 English Compare
v3 2019-02-16 English Compare
v2 2019-01-22 French Compare
v1 2019-01-22 English Compare

Showing 1 to 11 of 11